Results 221 to 230 of about 55,599 (265)

Different Facets of Competition in the Pharmaceutical Sector: Preliminary Findings of the European Commission’s Sector Inquiry into Pharmaceuticals

Archivum Immunologiae et Therapiae Experimentalis, 2010
The pharmaceutical sector is a part of today's economy in which the relationship between patents and competition has been receiving increasing attention. The European Commission's inquiry into this sector adds to the ongoing debate. Its Preliminary Report, published in November 2008, explains and quantifies a number of practices adopted by individual ...
openaire   +2 more sources

Does intellectual capital investment enhance firm performance? Evidence from pharmaceutical sector in China

Technology Analysis and Strategic Management, 2021
, , Ge Fengli
exaly  

The Impact of Mergers and Acquisitions and Sustainability on Company Performance in the Pharmaceutical Sector

Sustainability, 2021
Alin Opreana, Radu-Alexandru Şerban, Mihai Țichindelean   +2 more
exaly  

Blockchains in the Pharmaceutical Sector

2021
Muralidhar Kurni, Saritha Kuppala, K. Somasena Reddy, B. Manorama Devi   +3 more
openaire   +1 more source

Public subsidies for R&D and public sector pharmaceutical innovation

Applied Economics, 2021
Dimitrios Kourouklis
exaly  

The pharmaceutical sector

2012
Jonathan P. Northrup, Marina Tarasova, Lee Kalowski   +2 more
openaire   +1 more source

Abuse of Dominance in the EU Pharmaceutical Sector

SSRN Electronic Journal
This article is a comprehensive review of European Union and national level public enforcement actions in the pharmaceutical sector from 1974 to 2022. Whereas this research demonstrates that competition authorities are increasingly using competition law as a tool to hold pharmaceutical companies accountable in the pursuit of access to medicines goals ...
openaire   +2 more sources

The Irish pharmaceutical sector

Foreign multinational enterprises (MNEs) have played an important role in the development of the Irish economy in recent decades. Since the economic recovery began in 2014 after the financial crash, approximately half of the growth in the economy has come from the expansion in output of these MNEs (FitzGerald, 2023).
openaire   +3 more sources

Current Perspectives on the Development of Industry 4.0 in the Pharmaceutical Sector

Journal of Industrial Information Integration, 2020
Jorge Oliveira, Carla Reinhardt
exaly  

An insight into the pharmaceutical sector in Yemen during conflict: challenges and recommendations

Medicine, Conflict and Survival, 2020
P Ravi Shankar, Mohammed Alshakka, Mohamed Izham Mohamed Ibrahim   +2 more
exaly